desethylchloroquine has been researched along with Electrocardiogram QT Prolonged in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Baud, FJ; Clemessy, JL; Hoglund, RM; Megarbane, B; Tarning, J; Watson, JA; White, NJ | 1 |
Brüggemann, RJ; Burger, DM; de Mast, Q; Frenzel, T; Koch, BCP; Moes, DJAR; Pickkers, P; Polderman, FN; Rahamat-Langedoen, JC; Reijers, MHE; Rettig, TCD; Schouten, J; Ter Heine, R; van 't Veer, NE; van de Veerdonk, FL; van der Linden, PD; van Kimmenade, RRJ; van Paassen, J; van Raalte, R; van Rhee, KP; van Rossum, M; Windsant-van den Tweel, AV | 1 |
2 other study(ies) available for desethylchloroquine and Electrocardiogram QT Prolonged
Article | Year |
---|---|
Concentration-dependent mortality of chloroquine in overdose.
Topics: Adult; Antimalarials; Biotransformation; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dose-Response Relationship, Drug; Drug Overdose; Drug Repositioning; Electrocardiography; Female; Heart Diseases; Humans; Hydroxychloroquine; Long QT Syndrome; Malaria; Male; Pandemics; Pneumonia, Viral; Randomized Controlled Trials as Topic; Risk Assessment; Suicide; Suicide, Attempted | 2020 |
Chloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals.
Topics: Aged; Chloroquine; COVID-19 Drug Treatment; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Middle Aged; SARS-CoV-2 | 2021 |